Please ensure Javascript is enabled for purposes of website accessibility

Merck's Chief Digital Officer Leaves to Join Marriott

By Mark Prvulovic - Feb 20, 2020 at 9:25PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's a big loss for the healthcare giant, which now needs to find a replacement.

One of Merck's (MRK -0.46%) top executives has left the company and the big pharma sector, in general, to work elsewhere. Jim Scholefield, Merck's chief digital officer, has been hired by Marriott to fill a similar role. He'll be replacing Marriott's former chief information officer, Bruce Hoffmeister, who announced his retirement last September after working for the hotel chain for 30 years.

Scholefield had been hired by Merck back in late 2018 as the company's first chief digital officer at a time when other major pharmaceutical companies were making a big shift toward digital technology. At the time, his responsibilities included handling cybersecurity concerns for Merck, which had become a big worry following the 2017 NotPetya cyberattack, which cost the company over $1 billion in damages.

A jigsaw puzzle piece with a picture of a person being removed from the larger puzzle.

Image source: Getty Images.

Scholefield's tenure at Merck lasted less than two years before he decided to leave, and the company has no clear replacement in place. Dave Williams, Merck's Vice President of animal health IT, will be taking over as chief digital officer in the interim.

Big pharma's digital shift

Back in 2018, many large pharmaceutical companies, such as Novartis, Pfizer, and GlaxoSmithKline, had all been making moves to put a greater emphasis on digital technology. This included hiring new senior executive positions specifically focused on this goal. Sanofi's new CEO, Paul Hudson, is also working to boost the company's digital capabilities, which include having a separate chief digital executive on the company's leadership board.

Mark Prvulovic has no position in any of the stocks mentioned. The Motley Fool recommends Marriott International. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Merck & Co., Inc. Stock Quote
Merck & Co., Inc.
$90.60 (-0.46%) $0.42
Sanofi Stock Quote
$43.83 (-1.22%) $0.54
Pfizer Inc. Stock Quote
Pfizer Inc.
$49.75 (-0.72%) $0.36
Novartis AG Stock Quote
Novartis AG
$85.38 (-0.35%) $0.30
GSK Stock Quote
$34.95 (-3.00%) $-1.08
Marriott International, Inc. Stock Quote
Marriott International, Inc.
$163.18 (-0.54%) $0.89

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/15/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.